KUKJEON PHARMACEUTICAL Co., Ltd's latest marketcap:
As of 08/15/2025, KUKJEON PHARMACEUTICAL Co., Ltd's market capitalization has reached $148.39 M. According to our data, KUKJEON PHARMACEUTICAL Co., Ltd is the 22412th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 148.39 M |
| Revenue (ttm) | 97.51 M |
| Net Income (ttm) | 1.04 M |
| Shares Out | 49.97 M |
| EPS (ttm) | 0.02 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/27/2024 |
| Earnings Date | 08/14/2025 |
KUKJEON PHARMACEUTICAL Co., Ltd's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/15/2025 | ₩206.11 B | $148.39 M | 15.3% | 22412 |
| 12/30/2024 | ₩172.48 B | $115.56 M | -43.67% | 22355 |
| 12/28/2023 | ₩306.19 B | $235.77 M | -5.74% | 17841 |
| 12/29/2022 | ₩324.84 B | $256.62 M | -39.54% | 16556 |
| 12/30/2021 | ₩537.31 B | $451.34 M | 40.12% | 13987 |
| 12/30/2020 | ₩383.45 B | $352.78 M | 13620 |
Company Profile
About KUKJEON PHARMACEUTICAL Co., Ltd
KUKJEON PHARMACEUTICAL Co., Ltd is a leading chemical total solutions provider based in South Korea. Established in 1972 and headquartered in Anyang-si, the company specializes in delivering high-quality chemical-based products and services.
Core Services & Offerings
- Active Pharmaceutical Ingredients (API): Manufacturing and supply of APIs for pharmaceutical applications.
- Research & Development: Comprehensive R&D services, including molecular design and technical support.
- Quality Control & DMF Services: Ensuring product excellence through rigorous quality control and DMF compliance.
Product Portfolio
The company develops and supplies a diverse range of advanced chemical materials, including:
- Electronic Materials: Antistatic agents, UV curing agents, and low-dielectric monomers/polymers.
- Specialty Compounds: Low-resistance electrolytes, phosphine, silane, and boron compounds.
- Semiconductor Materials: High-performance materials for semiconductor manufacturing.
- Intermediates: Carbazole, boric acid, and fluorene intermediates for industrial applications.
Industry Focus
KUKJEON PHARMACEUTICAL serves a broad spectrum of industries, including:
- Pharmaceuticals
- Intermediate products
- New drug synthesis
- Specialty materials
The company holds multiple patents for its innovative manufacturing methods, reinforcing its position as a trusted partner in the chemical and pharmaceutical sectors.
Frequently Asked Questions
-
What is KUKJEON PHARMACEUTICAL Co., Ltd's (KOSDAQ-307750) current market cap?As of 08/15/2025, KUKJEON PHARMACEUTICAL Co., Ltd (including the parent company, if applicable) has an estimated market capitalization of $148.39 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ-307750) rank globally by market cap?KUKJEON PHARMACEUTICAL Co., Ltd global market capitalization ranking is approximately 22412 as of 08/15/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.